Evidence map›Paper›PMID 27407284›Full record

ReviewReumatologia2016

Erythema nodosum - review of the literature.

Małgorzata Chowaniec, Aleksandra Starba, Piotr Wiland

Open access · diamondAbstract readReview
In one paragraph

Review in Reumatologia, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
11.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 102 citations in OpenAlex.

  1. Scattered Erythema and Joint Swelling.Journal of acute medicine · 2026
    Article
  2. Article
  3. Article
  4. [Erythema nodosum].Dermatologie (Heidelberg, Germany) · 2025
    Article
  5. Article
  6. [Erythema nodosum].Zeitschrift fur Rheumatologie · 2024
    Article
  7. Article
  8. Panniculitis: A Cardinal Sign of Autoinflammation.Current rheumatology reviews · 2024
    Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Sex Differences in Susceptibility to Coccidioidomycosis.Open forum infectious diseases · 2022
    Article
  15. Article
  16. Atypical Presentation of Erythema Nodosum Following Pfizer-BioNTech COVID-19 Vaccine.Medical archives (Sarajevo, Bosnia and Herzegovina) · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Małgorzata ChowaniecDepartment of Rheumatology and Internal Diseases, University Hospital in Wroclaw, Wroclaw, Poland.
Aleksandra StarbaDepartment of Rheumatology and Internal Diseases, University Hospital in Wroclaw, Wroclaw, Poland.
Piotr WilandDepartment of Rheumatology and Internal Diseases, University Hospital in Wroclaw, Wroclaw, Poland.
Wroclaw Medical University · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Erythema nodosum is the most common form of panniculitis. It may have many aetiological factors. Erythema nodosum occurs three to five times more often in female patients. It appears as erythematous painful rounded nodules, located most often on the anterior surface of the lower extremities, and may be accompanied by systemic symptoms such as fever, malaise and arthralgia. During diagnosis, oncological vigilance should be maintained, because erythema nodosum may be a paraneoplastic symptom. It requires an interdisciplinary approach and exclusion of many underlying causes.

Indexed as

clinical imageerythema nodosumpanniculitis

Identifiers

PMID27407284
PMCPMC4918048
OpenAlexW2493526972

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.